5–15% avg body weight lost in short-term trials · FDA-approved since 1959
Phentermine 37.5 mg is a Schedule IV, prescription-only sympathomimetic appetite suppressant approved for short-term weight management in adults with obesity or overweight with additional weight-related risk factors, used alongside a reduced-calorie diet, increased physical activity, and medical supervision. At Vitercure, eligible adults complete a brief online intake,
consult with a licensed clinician via HIPAA-secure telehealth, and — if appropriate — receive a phentermine
prescription fulfilled by licensed US, Canadian, or UK pharmacy partners with discreet, trackable delivery.
Short-term appetite suppressant · US, Canada, UK pharmacies
Complete a short questionnaire. A licensed clinician reviews your history and cardiac risk factors. Phentermine dispensed and shipped if appropriate. No auto-subscription.
Select capsule count. Each pack is a one-time purchase — no auto-refill.
$89.00
One-time cost · telehealth visit included if approved · no subscription.
Phentermine 37.5mg — Source: Canada
Select capsule count. Each pack is a one-time purchase — no auto-refill.
$95.00
One-time cost · telehealth visit included if approved · no subscription.
Phentermine 37.5mg — Source: United Kingdom
Select capsule count. Each pack is a one-time purchase — no auto-refill.
$99.00
One-time cost · telehealth visit included if approved · no subscription.
Number of packs
HIPAA-compliant · Valid Rx required · Schedule IV controlled substance · Short-term use only
Licensed US, Canada & UK pharmacies
HIPAA-secure telehealth
Discreet trackable home delivery
Vitercure weight-loss education library
Phentermine — patient experiences at Vitercure
Individual results vary. Short-term use only as prescribed. These are illustrative of patient experience, not guarantees of outcome.
TM
"Lost 18 lbs in 8 weeks on phentermine. The appetite suppression was dramatic in the first month — I genuinely wasn't hungry. My clinician kept a close eye on my blood pressure throughout. It gave me the momentum I needed."
18 lbs · 8 weeks · 37.5mg
SA
"I tried GLP-1s first but the cost was prohibitive. Phentermine was affordable and effective for me as a kickstart. Down 22 lbs. I've since transitioned to lifestyle changes and have kept most of it off."
22 lbs · 10 weeks · Cost-effective
JL
"My doctor at Vitercure was thorough — checked my heart history, BP, all medications. I was a good candidate. 14 lbs in 6 weeks. The daily capsule was easy to remember. Side effect was mostly dry mouth."
14 lbs · 6 weeks · Cardiac screening done
What is Phentermine 37.5 mg?
Phentermine hydrochloride is a sympathomimetic amine anorectic — a medication that reduces appetite by
stimulating the release of norepinephrine and dopamine in the hypothalamus, the brain region that regulates
hunger. It was FDA-approved in 1959 and remains the most prescribed weight-loss medication in the United States.
At the 37.5mg strength, it represents the maximum commonly prescribed daily dose.
How phentermine suppresses appetite
Norepinephrine release in hypothalamus
Phentermine stimulates norepinephrine release in the lateral hypothalamus, directly dampening the hunger signal. This is the primary mechanism — patients typically notice a substantial reduction in appetite within the first week of therapy.
CNS stimulant effect
Like all amphetamine-class medications, phentermine has a mild stimulant effect — patients often report increased energy and alertness alongside reduced appetite. This also explains why it should be taken in the morning and why it is used short-term.
Who qualifies for phentermine?
Phentermine is indicated for adults with a BMI ≥30 kg/m², or BMI ≥27 with at least one weight-related
condition such as high blood pressure, type 2 diabetes, or high cholesterol. Importantly, phentermine
requires careful cardiovascular screening — it is contraindicated in patients with heart disease, uncontrolled
hypertension, hyperthyroidism, glaucoma, or history of substance use disorders. A Vitercure clinician
will review your full cardiac and metabolic history before any prescription is considered.
Phentermine vs GLP-1 medications — which is right for you?
Phentermine and GLP-1 medications like Saxenda, Wegovy, or Zepbound work through completely different
mechanisms and suit different patient profiles. Phentermine is oral, inexpensive, fast-acting, and
short-term. GLP-1 and dual-incretin medications are injectable, more expensive, slower to titrate, but
supported by more robust long-term clinical evidence and approved for chronic weight management. Some
patients use phentermine as a cost-effective kickstart before transitioning to GLP-1 therapy. Your
Vitercure clinician will help you navigate this decision based on your health profile, budget, and goals.
Also known as: Adipex-P® · Lomaira® · Suprenza® (all contain phentermine as the active ingredient)
How Well Does Phentermine Work? Clinical Evidence
Phentermine has one of the longest clinical track records of any weight-loss medication — over 65 years of
real-world use and multiple controlled trials. However, it is important to understand the limitations:
most phentermine trials were short (≤12 weeks) and did not include the rigorous follow-up or large sample
sizes of modern GLP-1 trials.
Phentermine clinical outcomes — what the evidence shows
5–15%
Body weight lost in short-term monotherapy trials vs diet alone
9.3%
Body weight lost at 1 year with phentermine+topiramate ER (Qsymia, CONQUER)
3–4 wks
Time to noticeable appetite suppression in most patients
Source: Li Z et al. Ann Intern Med. 2005 (meta-analysis). Gadde KM et al. Lancet. 2011;377:1341 (CONQUER). Short-term trials. Individual results vary. Not approved for long-term monotherapy.
Phentermine vs GLP-1 weight loss — honest comparison
Phentermine vs GLP-1 medications weight loss comparison
Medication
Trial avg weight loss
Trial duration
Key context
Phentermine 37.5mg
5–15%
Typically 12 weeks
Short-term only; not approved for long-term; lowest cost
FDA-approved; highest efficacy in class; once-weekly
All outcomes include diet + exercise. Phentermine trials are shorter and may not be directly comparable. Source: Li Z et al. Ann Intern Med. 2005; SCALE, STEP-1, SURMOUNT-1 trial publications.
When phentermine is often the right choice
Cost is a primary concern — ~$30–100/month vs $800–1,500 for GLP-1s.
Preferred oral medication over injectable therapy.
Short-term kickstart before transitioning to longer-term GLP-1 therapy.
No history of cardiovascular disease or uncontrolled hypertension.
When a GLP-1 or dual-incretin is likely better
Long-term chronic weight management needed (GLP-1s are approved for this).
Cardiovascular history that contraindicates phentermine stimulant effects.
Greater weight loss target (GLP-1s generally produce larger % body weight reduction).
Type 2 diabetes or prediabetes requiring glucose control alongside weight loss.
How to Take Phentermine 37.5 mg
Administration basics
Form: Oral capsule or tablet (37.5mg is the most common strength).
Frequency: Once daily, as prescribed — do not split or double the dose.
Timing: Take in the morning, before breakfast or 1–2 hours after breakfast. Late-day dosing causes insomnia in most patients.
Duration: Short-term use only — typically a few weeks, up to 12 weeks in most protocols. Your clinician determines the appropriate course.
Storage: Store at room temperature. Keep away from heat and moisture.
Controlled substance: Do not share. Do not take more than prescribed. Schedule IV in the US.
Why morning timing matters: Phentermine's stimulant properties can delay sleep onset if taken in the afternoon or evening. Most clinicians recommend taking it first thing in the morning, even before eating. If you notice difficulty sleeping on your current schedule, speak with your Vitercure prescriber about adjusting timing before changing your dose.
Short-term adjunct to diet + exercise in adults with obesity or overweight with risk factors
Phentermine vs Wegovy, Saxenda, Zepbound & Ozempic
The most common patient question at Vitercure: "Should I take phentermine or a GLP-1?" The honest answer is that they serve different patient profiles and treatment goals.
Phentermine vs GLP-1 medications full comparison
Feature
Phentermine
Saxenda®
Wegovy®
Zepbound®
Mechanism
CNS appetite suppression
GLP-1 agonist
GLP-1 agonist
Dual GIP+GLP-1
Form
Oral capsule
Daily injection
Weekly injection
Weekly injection
Avg weight loss
5–15% (12 wks)
8.0% (56 wks)
15.3% (68 wks)
22.5% (72 wks)
Approved duration
Short-term only
Chronic
Chronic
Chronic
Approx. monthly cost
~$30–100
~$350–1,400+
~$800–1,350+
~$700–1,100+
Controlled substance
Yes — Schedule IV
No
No
No
CV screening required
Yes — contraindicated in CV disease
Standard
Standard
Standard
Phentermine as a bridge to GLP-1 therapy: Some clinicians use phentermine as an affordable short-term kickstart to help patients achieve initial weight loss and build behavioral momentum before transitioning to a GLP-1 or dual-incretin medication for long-term management. Your Vitercure prescriber can help design this kind of sequential strategy if appropriate.
Phentermine Cost & Access — Vitercure
Phentermine is one of the most affordable prescription weight-loss medications available. Its cost advantage over GLP-1 therapies is significant — making it a compelling starting point for patients with budget constraints.
Vitercure phentermine pricing
30 capsules (US source)$89.00
60 capsules (US source)$159.00
90 capsules (US source)$219.00
Canada/UK optionsfrom $95.00
Telehealth evaluation included if approved. No auto-subscription. Prices shown before checkout.
Phentermine cost vs GLP-1 alternatives
Phentermine 37.5mg/month~$30–100
Saxenda (liraglutide)/month~$350–1,400+
Wegovy (semaglutide)/month~$800–1,350+
Zepbound (tirzepatide)/month~$700–1,100+
Retail approximations. Prices vary by pharmacy, insurance, and source. GLP-1 costs through Vitercure's international pharmacy partners may differ from US retail.
Insurance coverage: Phentermine may be covered by some insurance plans as a generic medication — it is generally less likely to face the coverage hurdles that GLP-1s commonly encounter. Confirm with your insurer. HSA/FSA funds may be applicable for prescription medications.
Phentermine Safety Information
This is not a complete list of warnings. Always review the full Prescribing Information and speak with a licensed clinician before starting phentermine.
Do not use phentermine if:
You have cardiovascular disease, uncontrolled hypertension, or history of stroke.
You have hyperthyroidism, glaucoma, or agitated states.
You have a history of drug abuse or dependence.
You are pregnant, breastfeeding, or may become pregnant.
You are taking MAO inhibitors or took them in the last 14 days.
Cardiovascular monitoring
Phentermine can increase heart rate and blood pressure. Vitercure clinicians perform baseline and ongoing cardiovascular screening. Contact your prescriber immediately for chest pain, shortness of breath, fainting, swelling in legs, or new or worsening mood changes.
Common side effects
Dry mouth (very common), difficulty sleeping, restlessness or nervousness, increased heart rate, elevated blood pressure, constipation or diarrhea, and headache. Most side effects are most pronounced in the first 1–2 weeks and lessen as the body adjusts. Taking phentermine in the morning reduces insomnia risk.
Phentermine and alcohol
Alcohol can amplify phentermine's cardiovascular effects and worsen dizziness, impaired judgment, or blood pressure changes. Most clinicians recommend avoiding or strictly limiting alcohol during phentermine therapy. This is one of the most common questions patients ask — discuss your specific situation with your Vitercure prescriber.
Is phentermine addictive?
Phentermine is chemically related to amphetamines and is classified as Schedule IV controlled substance due to potential for dependence with long-term use. This is why it is prescribed only short-term and under close medical supervision. Your Vitercure clinician will screen your history for substance use concerns before prescribing.
Phentermine 37.5 mg FAQ
Short-term clinical trials (typically 12 weeks) show average weight loss of 5–15% of body weight when phentermine is combined with a reduced-calorie diet and increased activity. The CONQUER trial of phentermine-topiramate (Qsymia) showed 9.3% average weight loss at 52 weeks. Individual results vary significantly based on starting weight, adherence to lifestyle changes, dose, and duration of treatment.
Phentermine hydrochloride 37.5mg has a half-life of approximately 20–24 hours, meaning it stays active in your system for most of the day from a single morning dose. Appetite suppression is typically most noticeable in the first 3–6 hours after taking the capsule, and patients report that evening hunger can return as levels decline. This is another reason morning dosing is standard.
Weight regain after stopping phentermine is common unless the underlying dietary patterns, physical activity habits, and behavioral strategies have changed during treatment. Phentermine is a short-term kickstart — Vitercure pairs it with a structured lifestyle program and education library so that habits built during therapy can persist. Some patients transition to GLP-1 medications for longer-term pharmacological support.
Phentermine is not FDA-approved specifically for PCOS, but weight loss — regardless of method — can improve PCOS-related insulin resistance, androgen levels, and menstrual regularity. In patients with PCOS who are candidates for phentermine (no cardiovascular contraindications), it may support short-term weight loss that in turn improves hormonal balance. Your Vitercure clinician will assess whether phentermine, a GLP-1, or metformin is most appropriate for your PCOS profile.
Adults with BMI ≥30, or ≥27 with weight-related conditions, who have no cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, substance use history, MAO inhibitor use, or pregnancy. Your Vitercure clinician reviews your full medical history and performs cardiovascular screening before prescribing.
Adipex-P® is a branded formulation of phentermine — they contain the same active ingredient (phentermine HCl 37.5mg). Other brands include Lomaira® (8mg dose) and Suprenza®. Vitercure partner pharmacies may dispense generic phentermine or specific branded formulations as prescribed — this will be clear before checkout.
Combining phentermine with GLP-1 medications is complex and not appropriate for most patients. The cardiovascular stimulant effects of phentermine may compound with the GI and cardiac profiles of GLP-1s. Some specialized obesity medicine clinicians use combination approaches in carefully selected patients, but this is not a standard protocol. Your Vitercure prescriber will determine whether any combination is appropriate for you.
Vitercure offers phentermine 37.5mg capsule packs from $89.00 (30-count, US source) to $239.00 (90-count, UK source). This is significantly less expensive than GLP-1 alternatives, which typically cost $700–1,500+ per month. Telehealth evaluation is included in the order if approved. No auto-subscription.
Yes, through Vitercure's HIPAA-secure telehealth platform. A licensed clinician reviews your medical history, cardiovascular risk factors, and medication list remotely and can prescribe phentermine if appropriate — without requiring an in-person clinic visit. A valid prescription is always required; phentermine cannot be dispensed without one.
How Much Weight Can You Lose on Phentermine?
The honest answer is: less than the GLP-1 headline numbers — but faster, cheaper, and with a well-documented
65-year track record. A 2005 meta-analysis published in the Annals of Internal Medicine found that phentermine
produced 5–15% body weight loss in short-term trials (typically 12 weeks) when combined with a reduced-calorie
diet. For a 220-lb patient, 10% weight loss represents 22 lbs — a clinically meaningful result that can
significantly improve blood pressure, blood sugar, cholesterol, and joint health.
Where phentermine differs most from GLP-1 options is in the approved duration. Wegovy patients in the STEP-1
trial lost an average of 15.3% over 68 weeks, and Zepbound patients in SURMOUNT-1 lost 22.5% over 72 weeks.
Phentermine's short-term approval means it cannot be used to achieve those kinds of extended outcomes as
monotherapy. However, some clinicians use phentermine as a fast-acting, cost-effective bridge — achieving
initial weight loss and behavioral momentum before transitioning patients to a GLP-1 for long-term maintenance.
Phentermine vs Wegovy vs Zepbound — Which Is Right for You?
These medications represent three fundamentally different pharmacological approaches to weight loss, suited
to different patient profiles. Phentermine suppresses appetite through direct CNS stimulation — it is oral,
fast-acting, and inexpensive, but approved only for short-term use and contraindicated in patients with
cardiovascular disease or hypertension. Wegovy and Ozempic (semaglutide) and Zepbound and Mounjaro
(tirzepatide) are GLP-1 receptor agonists delivered by weekly injection — approved for chronic weight
management with substantially larger average weight loss in trials, but at significantly higher cost.
The decision depends primarily on cardiovascular history, budget, weight-loss goals, and desired treatment
duration. Patients who cannot tolerate injections, who need a lower-cost option, or who want a short-term
kickstart often start with phentermine. Patients seeking maximum weight loss, long-term pharmacological
support, or who have prediabetes or metabolic syndrome typically do better on GLP-1 or dual-incretin therapy.
At Vitercure, a licensed clinician helps you navigate this decision based on your complete clinical picture.
Phentermine for PCOS — What the Evidence Shows
Polycystic ovary syndrome (PCOS) is strongly linked to insulin resistance and excess body weight. Even modest
weight loss of 5–10% of body weight can significantly improve PCOS-related symptoms — including menstrual
irregularity, elevated androgens, and fertility challenges — regardless of how that weight is lost. Because
phentermine can reliably achieve 5–15% weight loss in short-term use, it has been used in PCOS patients who
are appropriate candidates.
The key consideration is the contraindication profile: phentermine's cardiovascular effects rule it out for
patients with uncontrolled blood pressure — a common comorbidity in PCOS patients with significant metabolic
syndrome. For those patients, GLP-1 options (which also directly target insulin resistance) or metformin
are often preferred. Your Vitercure clinician will compare phentermine, GLP-1 therapy, and metformin
specifically in the context of your PCOS profile, blood pressure history, and reproductive goals.
“
Clinician perspective on phentermine
Phentermine gets unfairly dismissed in the GLP-1 era, and I think that's a mistake. For the right
patient — cardiovascular history clear, budget is a real constraint, no contraindications — a
short course of phentermine can provide a genuinely meaningful behavioral reset. Patients who
lose 10–15 lbs quickly often develop momentum and confidence that carries forward even after
the prescription ends. The key is pairing it with real lifestyle work. Phentermine alone,
without nutritional structure and activity, typically leads to weight regain within months.
Used as a bridge or a kickstart alongside solid habits, it still has an important role.
General perspective only. A Vitercure clinician will review your individual history before any treatment recommendation.
Medically Reviewed
Dr. Jane Rote, MD
Board-Certified in Endocrinology & Metabolism
Last medical review: November 2025
Content reviewed for clinical accuracy
Start phentermine with Vitercure
Answer a brief questionnaire. A licensed clinician reviews your cardiovascular history and medical profile.
If appropriate, phentermine 37.5mg is prescribed and shipped from licensed US, Canadian, or UK pharmacies
with discreet delivery. No auto-subscription.
